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Background
The gut associated lymphoid tissue (GALT) includes
around two thirds of the total lymphoid system. CD4+
T-cells in the GALT are a main target for HIV during
primary infection. Thus, immunization targetting GALT
is likely to be of importance for an effective vaccine
strategy. Transgenic plants expressing HIV antigens can
reach GALT conveniently. This system allows multiple
boosts, has simple logistics (no cold chain, no injections)
and large production capacity.
Methods
Three groups of mice were given extract from plant lines
expressing HIV-1 p24 at (A) low level (20 ng/feeding); (B)
high level (460 ng/feeding); (C) control (wild type, 0 ng).
No adjuvant was included. The extracts were administered
by gastric tube day 0, 14 and 28. On day 55 all mice were
given an intramuscular (i.m.) boost with 10 micrograms of
purified p24 antigen. Immune responses were determined
by measurement of p24-antibodies in serum by ELISA.
Results
The mice immunized by the low dose plant line (A)
showed a higher systemic immune response after i.m.
boost compared to the high dose group (B). The w.t. con-
trols (C) had undetectable p24-responses. The responses
in group A were 3 to 10 times higher (ELISA OD values)
than in group B. Pre-boost antibody responses were at
background levels in all groups. Preliminary analyses indi-
cate a predomninant Th1-type response (antigen-specific
IgG2a higher than IgG1).
Conclusion
Simple and inexpensive means of vaccination are impor-
tant in order to reach large numbers of people with effec-
tive vaccine regimens. The HIV-1 p24 low dose transgenic
plant extracts given orally showed a superior priming
effect in mice compared to the p24 high dose extracts.
This could be an immunization method and route worth
exploring further.
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